KATHMANDU, Oct 18: Nepal has recorded 591 new cases of COVID-19 along with 937 recoveries and nine deaths on Monday.

KATHMANDU, Oct 11: As many as 888 people recovered from COVID-19 on Monday, according to the latest information provided by the Ministry of Health and Population. Similarly, Nepal recorded 785 new cases of COVID--19 and 12 deaths from the deadly virus on the same day.

KATHMANDU, Oct 10: As many as 871 people recovered from COVID-19 in Nepal on Sunday, according to the latest information provided by the Ministry of Health and Population. Similarly, Nepal recorded 596 new cases of COVID-19 and 10 deaths from the deadly virus on the same day.

KATHMANDU, Oct 9: As many as 899 people recovered from COVID-19 in Nepal on Saturday, according to the latest information provided by the Ministry of Health and Population. Similarly, Nepal recorded 760 new cases of COVID--19 and 11 deaths from the deadly virus on the same day.

KATHMANDU, Oct 8: As many as 1,033 people recovered from COVID-19 on Friday, according to the latest information provided by the Ministry of Health and Population. Similarly, Nepal recorded 764 new cases of COVID--19 and ten deaths from the deadly virus on the same day.

KATHMANDU, Oct 8: In its bid to immunize all citizens above 18 years old against COVID-19, the Kathmandu Metropolitan City (KMC) is running a vaccination campaign from today targeting the Dashain festival.

KATHMANDU, Oct 6: Nepal recorded 805 new cases of COVID-19 along with 911 recoveries and eight deaths on Thursday, according to the latest information provided by the Ministry of Health and Population.

Enrollment for efficacy trial of COVID-19 vaccine begins

Published On: October 7, 2021 11:48 AM NPT By: Republica

KATHMANDU, Oct 7: Enrollment for Sanofi and GSK’s Phase 3 efficacy trial of COVID-19 vaccine has started in Nepal.

KATHMANDU, Oct 6: Nepal recorded 1,043 new cases of COVID-19 along with 891 recoveries and six deaths on Wednesday, according to the latest information provided by the Ministry of Health and Population.

Oct 6: The effectiveness of the Pfizer Inc (PFE.N)/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47% from 88% six months after the second dose, according to data published on Monday that U.S. health agencies considered when deciding on the need for booster shots.